Category: In the News

Pharmaceutical advertisers are one of the biggest television spenders in the U.S. Collectively, they’ve injected $2.18 billion into linear media this year already, according to iSpot data.

But this year’s upfronts have thrown a spotlight on the growing list of challenges facing marketers in the space, from turbulent economic conditions to the looming threat of a pharmaceutical TV ad ban floated by U.S. secretary of health Robert F. Kennedy Jr.

“Pharma is the port in the storm. When other categories might be pulling back, it’s not unusual to see pharma stay flat to up, in terms of overall investment,” Publicis Health Media CEO Andrea Palmer told Digiday.

Continue reading this article on digiday.com. Sign up for Digiday newsletters to get the latest on media, marketing and the future of TV.

,Read More

You’ve seen the headlines: “The TCF is illegal.” “RTB ruled unlawful.” But as usual in advertising, the truth is less clickbait, more caveat.

What did happen is this: Belgium’s Court of Appeal finally weighed in on the long-running saga around the Transparency and Consent Framework — the industry’s de facto permission slip for tracking-based advertising in the European Union. Depending on who you ask, the ruling was a win for privacy, a loss for business or just more fuel for a fight that’s far from over. One thing’s clear: it didn’t end the debate — it sharpened it.

Still parsing it all? We’ve got you. Here’s what actually happened, and what it means for Google, Amazon, IAB Europe and just about everyone else in the tracking-based ad economy. 

Continue reading this article on digiday.com. Sign up for Digiday newsletters to get the latest on media, marketing and the future of TV.

,Read More